Order Article Reprints

Akinosoglou K, Tsoupra S, Chandroulis I, Polyzou E, Dimakopoulou V, Moulakakis K, Perperis A, Karlafti E, Ztriva E, Patriarcheas V, et al. Prophylactic vs. Intermediate Tinzaparin Dosage for the Thromboprophylaxis of Acutely Ill Medical Patients at High Risk of Venous Thromboembolism. Medical Sciences. 2025; 13(4):291. https://doi.org/10.3390/medsci13040291

Akinosoglou, Karolina, Stamatia Tsoupra, Ioannis Chandroulis, Eleni Polyzou, Vasiliki Dimakopoulou, Konstantinos Moulakakis, Angelos Perperis, Eleni Karlafti, Elvira Ztriva, Vasileios Patriarcheas, and et al. 2025. "Prophylactic vs. Intermediate Tinzaparin Dosage for the Thromboprophylaxis of Acutely Ill Medical Patients at High Risk of Venous Thromboembolism" Medical Sciences 13, no. 4: 291. https://doi.org/10.3390/medsci13040291

Akinosoglou, K., Tsoupra, S., Chandroulis, I., Polyzou, E., Dimakopoulou, V., Moulakakis, K., Perperis, A., Karlafti, E., Ztriva, E., Patriarcheas, V., Davlouros, P., Kaiafa, G., & Savopoulos, C. (2025). Prophylactic vs. Intermediate Tinzaparin Dosage for the Thromboprophylaxis of Acutely Ill Medical Patients at High Risk of Venous Thromboembolism. Medical Sciences, 13(4), 291. https://doi.org/10.3390/medsci13040291